Clonal Theory and Tumor Progression
Based on their origin, neoplasms are subdivided into monoclonal and polyclonal:
- Monoclonal tumors account for the overwhelming majority. They are characterized by primary unicentric growth from a single cell precursor. However, in a mature node, monoclonality is often the result of clonal selection, when the most viable and aggressive clone gradually displaces the others.
- Polyclonal tumors are significantly less common and present with multicentric growth. Classic examples include colorectal polyposis, as well as multicentric variants of liver and breast cancer.
Willis's field cancerization theory explains how several closely spaced foci of transformation merge during growth into a single visually uniform node containing different clones. This is a key mechanism in the formation of recurrences following surgical removal.
During clonal evolution, malignant tumors continuously accumulate secondary mutations, increasing heterogeneity (polyclonality). In contrast, benign neoplasms maintain the dominance of a single clone throughout their entire existence.
Local and Systemic Effects on the Organism
The impact of a neoplasm on the body consists of local changes and general disorders.
Local manifestations:
- Metabolic shifts in the microenvironment.
- Mechanical compression and direct destruction of adjacent tissues.
- Invasion into vessel walls with the development of local venous stasis.
- Necrosis and ulceration of tumor tissue leading to hemorrhage and secondary infection.
Systemic consequences:
- Development of anemia syndrome and cancer intoxication.
- Cancer cachexia is marked exhaustion of the body accompanied by brown atrophy of skeletal muscles, liver, and myocardium. Its pathogenesis includes a metabolic component (increased protein metabolism turning the tumor into a nutrient "trap") and a cytokine component (active production of TNF-α, known as cachectin, by macrophages).
Paraneoplastic Syndromes
Paraneoplasia refers to a complex of symptoms caused by a tumor at a distance, rather than by its local growth or metastases.
Main variants of paraneoplastic reactions:
- Endocrinopathies: occur in hormonally active neoplasms. Thus, anterior pituitary adenomas or neuroendocrine lung carcinomas can trigger Cushing's syndrome, while parathyroid adenomas and lung cancer can trigger hypercalcemia with osteoporosis.
- Hemostasis disorders (thrombopathies): activation of coagulation processes by tumor factors leads to the development of migratory thrombophlebitis, non-bacterial thrombotic endocarditis, and afibrinogenemia.
- Immunopathological processes: are mediated by antibodies, cytotoxic reactions, or circulating immune complexes, manifesting as neuropathies, dermatopathies, and myopathies.
Antitumor Immunity and Causes of Its Failure
The body's defense is based on DNA repair, the balance of cellular oncogenes and suppressor genes, as well as immune system reactions.
The following effector cells play a key role:
- Cytotoxic T lymphocytes (CTLs): recognize tumor antigens presented by MHC class I molecules.
- Natural killer (NK) cells: lyse neoplastic cells without prior sensitization—either directly or by binding to the Fc fragment of specific antibodies.
- Macrophages: exert a direct damaging effect through the secretion of TNF-α or participate in a specific response upon contact with Fc antibody fragments and under the action of γ-interferon released by T lymphocytes.
The humoral response is mediated by the activation of the complement system with the formation of the membrane attack complex or the recruitment of NK cells and macrophages to the Fc fragment of antibodies.
Causes of ineffective defense: immunosuppression developing in cancer patients, the "antigenic escape" phenomenon (simplification and lability of tumor antigens), as well as paradoxical stimulation of neoplasm growth by antitumor antibodies.
Briefly: answers to topical questions
What types of paraneoplastic endocrinopathies exist and with which tumors do they occur?
The following types of paraneoplastic endocrinopathies occur in various neoplasms:
- Cushing's disease and syndrome — associated with anterior pituitary adenomas and neuroendocrine lung tumors; Cushing's syndrome is also observed in thymic carcinoid.
- Hypercalcemia and osteoporosis — associated with parathyroid adenomas and lung cancer.
- Ectopic ADH production — associated with thymic carcinoid; in lung cancer, paraneoplastic endocrinopathies are associated with the hyperproduction of hormones, including ADH.
- Carcinoid syndrome — associated with thymic carcinoid; sources indicate the diagnosis of carcinoid syndrome in neuroendocrine tumors of the lung and stomach.
- In lung cancer, paraneoplastic endocrinopathies may be associated with the hyperproduction of ACTH, ADH, parathyroid hormone, estrogens, and serotonin.
- In hepatocellular carcinoma, paraneoplastic syndromes in a small proportion of patients manifest as hypoglycemia, erythrocytosis, and hypercalcemia.
What are the causes of ineffective antitumor immunity?
Ineffectiveness of antitumor immunity is caused by the development of immunosuppression, immunological tolerance, and tumor defense mechanisms. The main causes include:
- The "antigenic escape" phenomenon — associated with antigenic lability, cell simplification, mutation, or modulation of antigens.
- Alteration of MHC expression — loss of classical MHC-I molecules while preserving non-classical ones, which blocks the reaction of T cells and NK lymphocytes.
- Suppression of lymphocyte activity — blockade of the expression of the receptor complex ζ-chain.
- Activation of regulatory T cells — secretion of immunosuppressive cytokines TGFβ and IL-10.
- Paradoxical growth enhancement — stimulation of the tumor under the influence of antitumor antibodies.
What stages does the malignant tumor metastasis process include?
The process of malignant tumor metastasis is a multistep cascade. It includes four main stages:
- Formation of a metastatic tumor subclone.
- Vascular lumen invasion (intravasation) — detachment of the malignant cell from the primary node, penetration into the wall of a blood or lymphatic vessel, and entry into its lumen.
- Circulation of the tumor embolus in the bloodstream or lymph flow; during this process, the tumor cell may attach to the endothelium of the vessel wall.
- Settling at a new site with the formation of a secondary tumor — extravasation, cell exit into the surrounding tissue, proliferation, and formation of a metastatic node.
What is the tumor "antigenic escape" phenomenon and what are its precise mechanisms?
The "antigenic escape" phenomenon is the ability of a tumor to evade immune surveillance due to antigenic lability and antigenic simplification of cells. Precise mechanisms include:
- Alteration of MHC expression — loss of classical MHC-I molecules while preserving non-classical ones (ideal escape). As a result, the cell becomes inaccessible to both cytotoxic CD8+ T lymphocytes and NK cells.
- Mutation or modulation of antigens — the disappearance of a tumor-specific antigen from the cell surface (e.g., upon exposure to antibodies), making its recognition by the immune system impossible.
The causes of weak immune defense are easily remembered by the three "I" rule: Immunosuppression, Immune escape (simplification), and Enhancement of tumor growth by antibodies.
Class and exam questions
What is the difference between monoclonal and polyclonal origin of a tumor?
A monoclonal tumor develops from a single transformed cell and grows unicentrically as a single node, although clone selection can create the appearance of monoclonality even in initially heterogeneous tumors. Polyclonal tumors arise from multiple cells, grow multicentrically, and are less common (e.g., in intestinal polyposis).
What is the pathogenesis of cancer cachexia?
Cachexia develops due to metabolic exhaustion, in which the tumor actively consumes nutrients (stimulating protein metabolism), and the effects of the cytokine TNF-α (cachectin) secreted by macrophages. This leads to profound wasting and brown atrophy of the myocardium, liver, and muscles.
What is Willis's tumor field theory?
This theory describes multicentric growth, in which several closely situated foci of cellular transformation merge into a single uniform node. This mechanism explains why relapses can occur in the same location after surgical excision of a tumor.
How does a tumor affect the hemostatic system as part of paraneoplasia?
By producing procoagulant factors, the tumor enhances coagulation processes. This manifests as thrombocytopathies: migratory thrombophlebitis, non-bacterial thrombotic endocarditis, and afibrinogenemia.
What else to study on this topic
- Mechanisms of clonal evolution during malignancy and metastasis
- Pathomorphology of organ brown atrophy in cancer cachexia
- Endocrinopathies in pituitary and lung tumors: diagnostic criteria
- The role of MHC I receptors and Fc fragments in the antibody immune response
- The phenomenon of tumor "antigenic escape" from immune control factors
Master the entire topic in the "Pathological Anatomy" course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "Tumor-Host Interaction" and 4,414 more subjects
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 153 video lessons on the subject
Other topics in the section "Tumor Growth"
Free video lessons: pathological anatomyShort lessons with study notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.